These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33840740)

  • 1. Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study.
    Liu Y; Guo QF; Chen JL; Li XR; Hou F; Liu XY; Zhang WJ; Zhang Y; Gao FF; Zhang YZ; Cui BX; Liu NF
    Chin Med J (Engl); 2021 Apr; 134(8):954-962. PubMed ID: 33840740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M
    Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Hua L; Wei M; Feng C; Li S; Wen X; Chen S
    Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer.
    Wei LC; Li X; Zhang Y; Dang YZ; Li WW; Li JP; Zhao LN; Liu SJ; Li X; Shi M
    Medicine (Baltimore); 2018 Apr; 97(14):e0331. PubMed ID: 29620659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.
    Ge J; Sun J; Li J; Zhang Q; Lv X; Chen B
    Int J Clin Oncol; 2020 May; 25(5):948-954. PubMed ID: 32236755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chemotherapy cycles on oncological outcomes in elders with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Tangkananan A; Thongkhao P; Janmunee N; Hanprasertpong J
    J Med Imaging Radiat Oncol; 2022 Oct; 66(7):1014-1021. PubMed ID: 35695633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
    Ao M; Li P; Sun D; Li X; Xu S; Hao Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2179915. PubMed ID: 37001548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients.
    Lee SY; Lee DH; Cho DH
    Medicine (Baltimore); 2023 Jan; 102(3):e32727. PubMed ID: 36701697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Liu J; Tang G; Zhou Q; Kuang W
    Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
    Lee J; Kim TH; Kim GE; Keum KC; Kim YB
    J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Therapeutic Value of Adjuvant Chemotherapy after Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Wang YN; Zhong ML; Liang MR; Yang JT; Zeng SY
    Gynecol Obstet Invest; 2023; 88(5):286-293. PubMed ID: 37497957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy.
    Lee HJ; Kim JM; Chin YJ; Chong GO; Park SH; Lee YH; Hong DG; Lee YS
    Anticancer Res; 2020 Jan; 40(1):451-458. PubMed ID: 31892600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
    Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
    J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups.
    Todo Y; Watari H
    Chin J Cancer Res; 2016 Apr; 28(2):221-7. PubMed ID: 27199520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
    Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.